- Joined
- Aug 11, 2011
- Messages
- 67,645
- Reaction score
- 38,787
- Gender
- Female
- Political Leaning
- Conservative
From Fox News:
LONDON — Oxford University says trials of a coronavirus vaccine that it is developing with pharmaceutical company AstraZeneca will resume, days after being paused due to a reported side-effect in a patient in the U.K.
In a statement, the university said in large trials such as this “it is expected that some participants will become unwell and every case must be carefully evaluated to ensure careful assessment of safety.”
It said that globally some 18,000 people have received the vaccine as part of the trial. Oxford, AstraZeneca to resume coronavirus vaccine trial | Fox Business
Axios notes "The big picture: A number of coronavirus vaccines are in phase 3 trials, but AstraZeneca remains a frontrunner. The company says it hopes to complete its vaccine by year's end." AstraZeneca to resume COVID-19 vaccine trials - Axios
NIH launches clinical trials network to test COVID-19 vaccines and other prevention tools | National Institutes of Health (NIH)
I'm glad that the trial has resumed and also that other vaccines are in Phase 3.
LONDON — Oxford University says trials of a coronavirus vaccine that it is developing with pharmaceutical company AstraZeneca will resume, days after being paused due to a reported side-effect in a patient in the U.K.
In a statement, the university said in large trials such as this “it is expected that some participants will become unwell and every case must be carefully evaluated to ensure careful assessment of safety.”
It said that globally some 18,000 people have received the vaccine as part of the trial. Oxford, AstraZeneca to resume coronavirus vaccine trial | Fox Business
Axios notes "The big picture: A number of coronavirus vaccines are in phase 3 trials, but AstraZeneca remains a frontrunner. The company says it hopes to complete its vaccine by year's end." AstraZeneca to resume COVID-19 vaccine trials - Axios
NIH launches clinical trials network to test COVID-19 vaccines and other prevention tools | National Institutes of Health (NIH)
I'm glad that the trial has resumed and also that other vaccines are in Phase 3.